Department of Otolaryngology - Head and Neck Surgery, University of Iowa Hospitals and Clinics, Iowa City, Iowa, U.S.A.
Department of Radiology, University of Iowa Hospitals and Clinics, Iowa City, Iowa, U.S.A.
Laryngoscope. 2021 May;131(5):E1450-E1456. doi: 10.1002/lary.29279. Epub 2020 Nov 17.
OBJECTIVES/HYPOTHESIS: To apply a novel sialography classification system to identify parotid and submandibular ductal findings following I-131 therapy and to assess correlates to dose and duration of symptoms.
Retrospective single-center case series.
Patients who underwent sialography between February 2008 and February 2019 after previously receiving I-131 treatment were identified via a retrospective chart review. Their sialograms were systematically evaluated and scored by applying the Iowa parotid sialogram scale to also include submandibular gland analysis.
From 337 sialograms, 30 (five submandibular, 25 parotid) underwent analysis. Ductal stenosis was identified in all sialograms and was graded as moderate (>50%-75%) in 7/30 cases and severe (>75%) in 15/30 cases. The distal (main) duct was narrowed in 23/30 cases. No association was identified between degree of ductal stenosis and I-131 dose (P = .39), age (P = .81), or time from I-131 therapy to sialogram (P = .97).
The Iowa parotid sialogram scale was successfully applied to report abnormalities of the parotid and submandibular ductal system. The most common manifestation of I-131-associated sialadenitis was a severe stenosis within the distal salivary duct. No statistically significant association was found between degree of ductal stenosis and dose of I-131, age, or duration of symptoms.
4 Laryngoscope, 131:E1450-E1456, 2021.
目的/假说:应用一种新的唾液腺造影分类系统来识别放射性碘-131 治疗后腮腺和颌下腺导管的发现,并评估与剂量和症状持续时间的相关性。
回顾性单中心病例系列研究。
通过回顾性病历审查,确定了 2008 年 2 月至 2019 年 2 月间接受 I-131 治疗后进行唾液腺造影的患者。通过应用爱荷华州腮腺唾液腺造影评分系统对其唾液腺造影进行系统评估和评分,同时包括颌下腺分析。
在 337 例唾液腺造影中,有 30 例(5 例颌下腺,25 例腮腺)进行了分析。所有唾液腺造影均发现导管狭窄,其中 7/30 例为中度(>50%-75%),15/30 例为重度(>75%)。30 例中有 23 例远端(主)导管狭窄。导管狭窄程度与 I-131 剂量(P=0.39)、年龄(P=0.81)或 I-131 治疗至唾液腺造影的时间(P=0.97)之间无相关性。
爱荷华州腮腺唾液腺造影评分系统成功地应用于报告腮腺和颌下腺导管系统的异常。I-131 相关唾液腺炎最常见的表现是远端唾液管严重狭窄。导管狭窄程度与 I-131 剂量、年龄或症状持续时间之间无统计学显著相关性。
4 级喉镜,131:E1450-E1456,2021 年。